For example, in the specific pathway where the C-terminal transactivation domain of HIF-1α promotes the progression of AKI to chronic kidney disease, the presence of unknown intermediate steps or synergistic factors remains to be elucidated (Li et al., 2021a). This evidence concerns the gene HIF1A and chronic kidney disease.